ACADIA Pharmaceuticals: Q2 Earnings Insights



ACADIA Pharmaceuticals ACAD reported its Q2 earnings results on Monday, August 8, 2022 at 04:05 PM.

Here's what investors need to know about the announcement.


ACADIA Pharmaceuticals beat estimated earnings by 16.0%, reporting an EPS of $-0.21 versus an estimate of $-0.25.

Revenue was up $19.34 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.1 which was followed by a 5.33% drop in the share price the next day.

Here's a look at ACADIA Pharmaceuticals's past performance:


Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.6 -0.24 -0.26 -0.31
EPS Actual -0.7 -0.27 -0.09 -0.27
Revenue Estimate 121.92M 135.60M 127.75M 126.15M
Revenue Actual 115.47M 130.76M 131.61M 115.22M

To track all earnings releases for ACADIA Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!